MedPath
NMPA Approval

Mirabegron Sustained-release Tablets

国药准字HJ20171299

March 15, 2022

H20171299

Drug Information

米拉贝隆缓释片

贝坦利

片剂

50mg

化学药品

March 15, 2022

March 14, 2027

Company Information

Applicant Company

Sylviusweg 62,2333 BE Leiden,The Netherlands

Manufacturing Company

avara pharmaceutical technologies inc.

3300 Marshall Avenue,Norman,OK 73072,USA

© Copyright 2025. All Rights Reserved by MedPath
米拉贝隆缓释片 - NMPA 批准文号 | MedPath